The Biomedical Research for the 21st Century (BioMed21) Collaboration initially grew out of a 2015 review publication authored by a diverse group of eminent scientists who recognized the translational limitations of the current paradigm in biomedical research and drug discovery built on animal models, and the need for change. 

We are an international team of scientists, policy experts and communication specialists who are passionate about scientific progress and deeply value human and animal lives. We believe that the unprecedented development of New Approach Methodologies (NAMs) such as organs-on-chip, computational methods or bioprinting can put science on a path to eliminating the use of animals in laboratories, while offering researchers new and powerful tools to tackle the major human health challenges of this century.  

We articulate this ambitious long-term vision beneficial to animals as well as to patients around attainable policy goals and scientific projects that bring added value to the scientific community in areas as diverse as education, funding and scientific publishing. 

Respect, dialogue and inclusion of diverse viewpoints are core values of the BioMed21 Collaboration, and we work in partnership with academic institutions, governments, charities, agencies and the corporate sector.